a high CACS, no LRP was detected in 8 (40.0%) subjects. Large LRP having a maximum LCBI in 4 mm ≥400 were infrequent, found in only 5 (25.0%) of 20 subjects and in only 5 (1.9%) of 268 10-mm coronary segments analyzed. Conclusions-Among individuals with a CACS ≥300 Agatston units mostly on statins, CACS correlated with total plaque volume but not LCBI. This observation may have implications on coronary risk among individuals with a high CACS considering that it is coronary LRP, rather than calcification, that underlies the majority of acute coronary events. (Circ Cardiovasc Imaging. 2017;10:e006282.
A mong asymptomatic individuals with no prior history of coronary artery disease, a coronary artery calcium score (CACS) provides incremental risk stratification for future coronary events beyond assessment of traditional risk factors. [1] [2] [3] Individuals having a CACS ≥300 have a 7-fold increased risk of coronary death or myocardial infarction (MI), and a cumulative incidence of coronary events that exceeds 10% for 5 years. 2 Although a high CACS is a robust predictor of coronary risk, it is not coronary calcification per se that underlies most MIs. Rather, postmortem studies have demonstrated that the majority of MIs are triggered by rupture of a lipid-rich thinned-cap fibroatheroma leading to thrombus formation. [4] [5] [6] It remains unknown whether CACS, which correlates with the overall burden of atherosclerosis in the coronary arteries, [7] [8] [9] is also a marker of underlying coronary lipid burden.
See Editorial by Maehara and Stone See Clinical Perspective
The presence of lipid-rich plaque (LRP) can now be reliably identified in vivo using intracoronary near-infrared spectroscopy (NIRS). 10 Prior in vivo NIRS studies have demonstrated that the majority of plaques triggering MI have a large lipid burden exceeding an NIRS-derived maximum lipid core burden index in 4 mm (maxLCBI 4 mm ) of 400. [11] [12] [13] The present study was undertaken to determine the frequency of such large LRP in those with a high CACS and to determine whether the CACS correlates with the burden of lipid in the coronary arteries. This was accomplished by performing multivessel intracoronary NIRS and intravascular ultrasound (IVUS) imaging in asymptomatic individuals with no prior history of cardiovascular events who had a screening CACS ≥300 and were mostly taking statin therapy.
Methods

Study Population
Study participants were recruited from the group of asymptomatic individuals undergoing CACS for clinical risk stratification at imaging
Background-This study sought to determine the frequency of large lipid-rich plaques (LRP) in the coronary arteries of individuals with high coronary artery calcium scores (CACS) and to determine whether the CACS correlates with coronary lipid burden. Methods and Results-Combined near-infrared spectroscopy and intravascular ultrasound was performed in 57 vessels in 20 asymptomatic individuals (90% on statins) with no prior history of coronary artery disease who had a screening CACS ≥300 Agatston units. Among 268 10-mm coronary segments, near-infrared spectroscopy images were analyzed for LRP, defined as a bright yellow block on the near-infrared spectroscopy block chemogram. Lipid burden was assessed as the lipid core burden index (LCBI), and large LRP were defined as a maximum LCBI in 4 mm ≥400. Vessel plaque volume was measured by quantitative intravascular ultrasound. Vessel-level CACS significantly correlated with plaque volume by intravascular ultrasound (r=0.69; P<0.0001) but not with LCBI by near-infrared spectroscopy (r=0.24; P=0.07). DespiteLipid Burden and Coronary Calcium Score sites within Spectrum Health (Grand Rapids, MI). Individuals meeting the following criteria were considered for study inclusion: (1) CACS was performed within the past 12 months for risk stratification; (2) the total CACS was ≥300 Agatston units; (3) the individual was asymptomatic; (4) there was no prior history of coronary artery disease, MI, percutaneous coronary intervention, or coronary artery bypass surgery; and (5) the individual was at least 18 years of age, was not pregnant, and was able to provide written informed consent. Individuals with an estimated glomerular filtration rate <60 mL/ min per 1.73 m 2 were excluded from study participation. Individuals meeting criteria for study inclusion provided informed consent for coronary angiography and intracoronary NIRS-IVUS imaging. The study was approved by the local institutional review board, and all study participants provided written informed consent.
CACS Measurements
Prospective ECG-triggered noncontrast computed tomography cardiac images were acquired using a multidetector system according to local CACS imaging protocols. For the present analysis, the CACS (Agatston score) was calculated by 2 investigators, who were blinded to the NIRS-IVUS findings, using Aquarius software (iNtuition Edition, version 4.4.11, TeraRecon, Inc, Foster City, CA). The total CACS scores reported in this study included all calcification within all coronary arteries and their branches. However, vessellevel CACS values, which were used to study correlations with NIRS-IVUS findings, only included calcification within segments of the vessel that were also imaged with NIRS-IVUS. The location at which the NIRS-IVUS imaging pullback was initiated in each vessel was captured by invasive angiography at the time of catheterization. Using the locations of side branches on the invasive angiograms as anatomic reference points, the length of vessel interrogated by NIRS-IVUS was identified on the computed tomography images. In this manner, calcification in vessel segments or branches that were not also imaged with NIRS-IVUS was excluded from vessel-level CACS values.
Invasive Coronary Angiography and Intracoronary Imaging
To minimize the risk of access site complications, radial arterial access was used in all cases. After obtaining arterial access, a 6-French guide catheter was used to perform coronary angiography, and a standard 0.014-inch guidewire was advanced into the distal segment of the coronary artery. After administering intracoronary nitroglycerin, a combined NIRS-IVUS catheter (Insight Catheter, TVC Imaging System, Infraredx, Burlington, MA), which acquires IVUS images with a frequency of 40 MHz and performs 30 000 NIRS measurements per 100 mm of artery scanned, was advanced into the distal segment of the vessel, and a motorized pullback was performed at 0.5 mm/s. This approach was used to image all major epicardial coronary artery segments having a diameter of >2.0 mm.
NIRS-IVUS Image Analysis
NIRS-IVUS images were interpreted off-line using commercially available software (CAAS IntraVascular, Pie Medical Imaging, Maastricht, The Netherlands). The NIRS-IVUS catheter provides automatic coregistration of NIRS and IVUS data. For NIRS-IVUS analysis, each vessel was divided into nonoverlapping 10-mm segments as previously described.
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IVUS Analysis
IVUS analysis was performed according to previously published methodology and expert consensus recommendations. 11, 12, 14 Beginning in the distal most aspect of each vessel and proceeding proximally, every 30th image was analyzed, yielding IVUS crosssections spaced 1 mm apart. The external elastic membrane and luminal contours were traced on each image, after which the analysis software automatically computed a plaque volume for the entire vessel. Plaque burden for each cross-sectional image was calculated as plaque and media area divided by external elastic membrane area. For each coronary segment, the maximum plaque burden was defined as the largest plaque burden recorded on a cross-sectional image within the 10-mm segment. The minimal luminal area within each 10-mm coronary segment was similarly recorded.
NIRS Analysis
NIRS images were considered technically inadequate in a 2-mm segment and excluded from further analysis if the corresponding block chemogram (a summary of the NIRS values in a 2-mm length of pullback) was black in color, indicating the absence of reliable data. [11] [12] [13] An LRP was defined as being present if at least one 2-mm block on the NIRS block chemogram was bright yellow in color. This definition was chosen because a yellow block on the NIRS block chemogram was previously validated against ex vivo human coronary specimens and shown to detect histologically proven fibroatheroma with a specificity of 97%. 15 To assess the amount of lipid present in each vessel and in each 10-mm segment, the lipid core burden index (LCBI) was calculated, defined as the fraction of pixels indicating lipid within a region multiplied by 1000. [11] [12] [13] Each vessel and 10-mm segment were also scanned for the maxLCBI 4 mm .
Statistical Analysis
Normally distributed continuous variables are shown as mean±SD. Non-normally distributed continuous variables are shown as median (25th, 75th percentile). Categorical variables are shown as count (frequency). Summary statistics were used to describe the baseline CACS and NIRS-IVUS findings. Fisher exact test for categorical variables and Wilcoxon rank-sum test for continuous non-normally distributed variables were used to compare baseline characteristics between subjects with and without a maxLCBI 4 mm ≥400 by NIRS.
The correlations between vessel-level CACS, vessel-level LCBI, vessel-level maxLCBI 4 mm , and vessel-level plaque volume were assessed using Spearman correlation coefficients. These vessel-level correlations were also evaluated separately for the left anterior descending artery, left circumflex artery, and right coronary artery. To account for multiple segment-level measurements per patient, the significance of the relationship between segment-level maxLCBI 4 mm and maximum plaque burden was assessed by multilevel modeling using random intercepts. Statistical analyses were performed using SAS (SAS Enterprise Guide software, version 7.1, SAS Institute Inc, Cary, NC).
Results
Study Population
Between May 2014 and May 2015, 57 vessels among 20 asymptomatic individuals with a screening CACS ≥300 Agatston units and no history of prior coronary events underwent invasive coronary angiography and multivessel NIRS-IVUS imaging. The baseline characteristics of the study population are shown in Table 1 . In brief, subjects were aged 62±5 years, and 19 (95.0%) were men. The median CACS of the study population was 550 (408, 1042) Agatston units, and the total CACS was >1000 Agatston units in 5 (25.0%) subjects. At the time of study enrollment, 18 (90.0%) subjects were taking statins, and the mean low-density lipoprotein was 80±20 mg/dL.
Procedural Characteristics
In all subjects, the right radial artery was used for arterial access. Total procedural time was 28±4 minutes. Procedures were completed with a fluoroscopy time of 8±2 minutes and an air kerma of 608±311 mGy. The mean length of NIRS-IVUS per vessel was 58±23 mm. The total length of vessels imaged per person was 166±62 mm. There were no procedural complications in any of the cases, and all subjects were discharged home on the same day as the procedure. Lipid Burden and Coronary Calcium Score
NIRS-IVUS Findings
NIRS Findings
Examples of 2 individuals having high calcium scores but markedly different NIRS findings are shown in Figure 1 . The presence of LRP was not universal among individuals with a high CACS because 8 (40.0%) subjects had no LRP detected by NIRS in any of their arteries. Large LRPs having a max-LCBI 4 mm ≥400 were infrequent, found in only 5 (25.0%) of 20 subjects, and were also focally distributed, found in only 5 (1.9%) of the 268 10-mm coronary segments analyzed (Table 2 ; Figure 2 ). There were no differences in baseline characteristics or statin therapy between subjects with and without a large LRP having a maxLCBI 4 mm ≥400 (Table 3) .
IVUS Findings
In contrast to the rare findings of large LRP by NIRS, lesions having an minimal luminal area ≤4.0 mm 2 by IVUS were common, detected in 14 of 20 (70.0%) individuals and in 39 of 268 (14.6%) 10-mm coronary segments (Table 2) . Lesions having a plaque burden ≥70% were found in 10 (50.0%) individuals and in 19 (7.1%) coronary segments ( Table 2) . A total of 15 (5.6%) lesions were identified that had both a plaque burden ≥70% and an minimal luminal area ≤4.0 mm 2 .
Combined NIRS-IVUS Findings
Among the 268 10-mm coronary segments analyzed, the relationship between plaque burden and maxCLBI 4 mm was found to be significant (P<0.0001) when assessed by multilevel modeling with random intercepts (Figure 3 ). Only 2 (0.7%) lesions were identified that had both a maxLCBI 4 mm ≥400 and a plaque burden ≥70% ( 
Discussion
To our knowledge, the present study is the first to report multimodality intracoronary imaging with combined NIRS-IVUS imaging in asymptomatic individuals with no history of a coronary event. The principal finding of the present study is that a high CACS, although considered to be the most robust noninvasive marker of future coronary risk, 16 is not universally indicative of underlying coronary artery lipid deposition because 40% of individuals with a CACS ≥300 Agatston units had no LRP detected by NIRS in a population mostly on statin therapy. The association of calcification with coronary risk has been attributed to CACS being a marker of the overall burden of atherosclerosis in the coronary arteries, 7-9 a correlation that was confirmed in the present study. Despite CACS being Categorical variables are shown as number (%). Continuous variables are shown as mean±SD except for triglycerides and CACS values which are shown as median (25th, 75th percentile). CACS indicates coronary artery calcium score; HDL, high-density lipoprotein; LAD, left anterior descending artery; LDL, low-density lipoprotein; and RCA, right coronary artery. Lipid Burden and Coronary Calcium Score a good marker of overall coronary atherosclerotic burden, we observed CACS to be a poor marker of coronary lipid burden because no significant correlation was found between vessellevel CACS and LCBI by NIRS. These observations may have implications on future coronary risk considering that it is coronary LRP, rather than calcification, that underlies the majority of acute coronary events. [4] [5] [6] [11] [12] [13] Future studies will be required to determine whether NIRS might be able to enhance the risk stratification currently provided to asymptomatic individuals with a high CACS.
NIRS Imaging in Calcified Arteries
The NIRS findings in the current study are supported by extensive comparisons of NIRS imaging with autopsy findings which demonstrated accurate detection of LRP by NIRS, using either the block chemogram or the LCBI metric. 15, [17] [18] [19] [20] Consistent with the concept that near-infrared light is capable of penetrating calcium, these histological studies have shown that the detection of lipid by NIRS is not blocked by the presence of overlying calcification. 17, 19 These prior ex vivo findings are now supported by the present in vivo observation that NIRS detects LRP even in extensively calcified vessels. In contrast, IVUS is incapable of identifying LRP under calcification because ultrasound cannot penetrate calcium. Furthermore, a prior comparison of optical coherence tomography with histological findings reported frequent misinterpretation of lipid as calcification and vice versa because both lipid and calcium generate signal-poor regions on optical coherence tomographic images that can be difficult to differentiate. 20 
Focal Nature of Large LRP
The frequency of large LRP observed in the present study is in accord with both the frequencies observed in autopsy studies and the frequency expected based on the known rate of coronary events in this patient population. In autopsy specimens from individuals dying of noncardiovascular causes, Cheruvu et al 21 reported histological evidence that ruptured plaques and thin-capped fibroatheromas were focally distributed, occupying <3% of the length of coronary arteries. The NIRS findings CACS indicates coronary artery calcium score; IVUS, intravascular ultrasound; LCBI, lipid core burden index; maxLCBI 4 mm , maximum lipid core burden index in 4 mm; MLA, minimal luminal area; and NIRS, near-infrared spectroscopy. Lipid Burden and Coronary Calcium Score among asymptomatic individuals in the present study are similar to those obtained by Cherevu et al, 21 in that large LRPs having a maxLCBI 4 mm ≥400 were also focally distributed, found in <2% of all coronary segments. Although the number of observations in the present study is too small to draw any conclusions about future risk, the signs of potential high-risk plaque detected by NIRS fit well with the expected outcomes in this group of 20 patients with a CACS >300. Detrano et al Relationship between segment-level lipid burden and maximum plaque burden in individuals with a high coronary artery calcium score (CACS). Among all 10-mm coronary segments from individuals with a high CACS, there was a significant relationship between the maximum lipid core burden index in 4 mm (maxLCBI 4 mm ) and maximum plaque burden. In the 268 10-mm coronary segments analyzed, there were only 5 (1.9%) large lipid-rich plaques having a maxLCBI 4 mm ≥400 and only 2 (0.7%) segments having both a maxLCBI 4 mm ≥400 and a plaque burden ≥70%. Lipid Burden and Coronary Calcium Score reported that the 5-year risk of coronary events in individuals with a CACS >300 is ≈10%. Hence, applying this event rate to the present population, 2 coronary events would be expected to occur for the next 5 years in the group of 20 patients studied. Considering that the majority of acute coronary events are triggered by a large LRP, [4] [5] [6] [11] [12] [13] the observation that NIRS detected a large LRP in only 5 of 268 10-mm coronary segments may fit well with the 2 events expected because rupture of a LRP does not always result in a clinical event.
Relevance of Large LRP in Those With a High CACS
The identification large LRPs among asymptomatic individuals with a high CACS might be important for 2 reasons. First, in prior cross-sectional studies of patients presenting with MI, the maxLCBI 4 mm ≥400 signal was shown to be highly specific for culprit lesions triggering the MI. [11] [12] [13] These positive cross-sectional studies have led to 2 prospective studies, LRP (Lipid-Rich Plaque Study; NCT02033694) and PROSPECT II (A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes; NCT02171065), testing the prognostic significance of focal NIRS findings for future site-specific coronary events. The results of these studies focused on secondary prevention will guide the potential use of NIRS imaging for primary prevention. Second, 2 prior observational studies have associated coronary lipid burden as detected by NIRS imaging in patients experiencing a coronary event, with the risk of future patient-level cardiovascular events. 22, 23 In one of these studies, those having a large LRP with a maxLCBI 4 mm ≥400 at a nonculprit site had a 10-fold increased risk of future patient-level major adverse cardiovascular events. 22 Whether the presence of a large LRP with a maxLCBI 4 mm ≥400, which was detected in only 25% of individuals in the present study, will likewise identify the subpopulation of individuals with a high CACS who are at greatest risk for future major adverse cardiovascular events will require further study.
Limitations
The primary limitation of the present study is that NIRS measurements were performed at a single center in only a small number of individuals. Another limitation is that 90% of subjects were already taking statin therapy at the time of enrollment and that the duration of statin therapy was unknown. Statins are known to impact that natural history of coronary atherosclerosis by inducing plaque regression and possibly triggering plaque stabilization through processes that may include reducing coronary lipid burden and promoting plaque IVUS; A) . In contrast, vessel-level CACS does not significantly correlate with lipid burden as assessed by the near-infrared spectroscopy (NIRS) lipid core burden index (LCBI; B). The 2 vessels (taken from 2 different study subjects) shown in (C), both of which have a high CACS, each have extensive plaque evident on the longitudinal IVUS images, but markedly different lipid burdens evident on the NIRS chemograms. These examples illustrate that a high CACS is not a reliable marker of underlying lipid-rich plaque and that NIRS is capable of detecting LRP even in the presence of extensive calcification. AU indicates Agatston units; and MaxLCBI 4 mm , maximum lipid core burden index in 4 mm. Lipid Burden and Coronary Calcium Score calcification. 24, 25 Thus, it is unknown whether the low frequency of LRP observed in the setting of statin therapy in this study, and the lack of significant correlation between CACS and NIRS lipid burden, would be similarly observed in a statin-naïve population.
That NIRS imaging is an invasive technique represents a limitation because performing NIRS in individuals with a high CACS undoubtedly carries a risk of procedure-related complications although none were observed in the present study. It remains unknown whether such an approach would be costprohibitive as a means of further risk-stratifying individuals with a high CACS. Furthermore, because of the physical constraints of passing an intracoronary imaging catheter into small distal segments of the coronary arteries and any small coronary branches, NIRS-IVUS is not capable of imaging the same length of vessel as computed tomography. In the present study, attempts to coregister the length of vessel imaged by NIRS-IVUS with the same length of vessel on computed tomography images were carefully conducted yet may be prone to error and thus represent another limitation. There are also limitations to the information provided by NIRS imaging. For instance, the intracoronary NIRS signal penetrates tissue to a depth of ≈1 mm. 23 Thus, it is possible that deeper lipid cores could be missed by the NIRS system. Furthermore, the NIRS imaging system is not currently capable of detecting a thin collagen cap, a feature likely important to the development of plaque rupture.
Conclusions
The presence of intracoronary LRP was not found to be universal among asymptomatic individuals with a high CACS, mostly on statins. Although CACS correlates with total plaque volume, CACS was not observed to correlate with the coronary lipid burden. These observations may have implications on future coronary risk considering that it is coronary LRP, rather than calcification, that underlies the majority of acute coronary events.
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